Trials / Unknown
UnknownNCT04747678
Adverse Effects of Ivermectin Used in Egypt During COVID-19
Tolerability and Adverse Effects of Using Multiple Doses of Ivermectin in Egypt During Covid 19 Pandemic
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- —
Summary
retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt
Detailed description
ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH protocol that has been published in November 2020 the study will document the adverse effects of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose regimens
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ivermectin | retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt |
Timeline
- Start date
- 2021-02-03
- Primary completion
- 2021-02-28
- Completion
- 2021-03-01
- First posted
- 2021-02-10
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04747678. Inclusion in this directory is not an endorsement.